Critical Roles of METTL3 in Translation Regulation of Cancer

被引:9
|
作者
Meng, Wangyang [1 ,2 ]
Xiao, Han [1 ]
Mei, Peiyuan [1 ]
Chen, Jiaping [1 ]
Wang, Yangwei [1 ]
Zhao, Rong [1 ]
Liao, Yongde [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Thorac Surg, Wuhan 430022, Peoples R China
[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Thorac Surg, Shanghai 200000, Peoples R China
基金
中国国家自然科学基金;
关键词
METTL3; m(6)A; translation regulation; post-transcriptional modification; eukaryotic initiation factor; RNA binding protein; cancer; MESSENGER-RNA; M(6)A METHYLATION; SUBUNIT; EXPRESSION; GENE; BREAST; EIF4E; TUMORIGENESIS; AMPLIFICATION; CLONING;
D O I
10.3390/biom13020243
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aberrant translation, a characteristic feature of cancer, is regulated by the complex and sophisticated RNA binding proteins (RBPs) in the canonical translation machinery. N6-methyladenosine (m(6)A) modifications are the most abundant internal modifications in mRNAs mediated by methyltransferase-like 3 (METTL3). METTL3 is commonly aberrantly expressed in different tumors and affects the mRNA translation of many oncogenes or dysregulated tumor suppressor genes in a variety of ways. In this review, we discuss the critical roles of METTL3 in translation regulation and how METTL3 and m(6)A reader proteins in collaboration with RBPs within the canonical translation machinery promote aberrant translation in tumorigenesis, providing an overview of recent efforts aiming to 'translate' these results to the clinic.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Roles of METTL3 in cancer: mechanisms and therapeutic targeting
    Chengwu Zeng
    Wanxu Huang
    Yangqiu Li
    Hengyou Weng
    Journal of Hematology & Oncology, 13
  • [2] Roles of METTL3 in cancer: mechanisms and therapeutic targeting
    Zeng, Chengwu
    Huang, Wanxu
    Li, Yangqiu
    Weng, Hengyou
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [3] METTL3 as a master regulator of translation in cancer: mechanisms and implications
    Esteva-Socias, Margalida
    Aguilo, Francesca
    NAR CANCER, 2024, 6 (01):
  • [4] METTL3 PROMOTES mRNA TRANSLATION TO DRIVE TUMORIGENESIS
    不详
    CANCER DISCOVERY, 2018, 8 (11) : 1346 - 1346
  • [5] Prognostic roles of dysregulated METTL3 protein expression in cancers and potential anticancer value by inhibiting METTL3 function
    Zhao, Rong
    Chen, Jiaping
    Wang, Yangwei
    Xiao, Han
    Mei, Peiyuan
    Lin, Wei
    Diao, Mingxin
    He, Shiwen
    Liao, Yongde
    Meng, Wangyang
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2024, 38 (05) : 924 - 939
  • [6] Regulation of Methylase METTL3 on Fat Deposition
    Luo, Gang
    Chen, Jialing
    Ren, Zhanjun
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 4843 - 4852
  • [7] The m6A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells
    Lin, Shuibin
    Choe, Junho
    Du, Peng
    Triboulet, Robinson
    Gregory, Richard I.
    MOLECULAR CELL, 2016, 62 (03) : 335 - 345
  • [8] Mining for METTL3 inhibitors to suppress cancer
    Li, Jiazhi
    Gregory, Richard I.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2021, 28 (06) : 460 - 462
  • [9] Mining for METTL3 inhibitors to suppress cancer
    Jiazhi Li
    Richard I. Gregory
    Nature Structural & Molecular Biology, 2021, 28 : 460 - 462
  • [10] New insight into the catalytic -dependent and -independent roles of METTL3 in sustaining aberrant translation in chronic myeloid leukemia
    Ianniello, Zaira
    Sorci, Melissa
    Ginistrelli, Lavinia Ceci
    Iaiza, Alessia
    Marchioni, Marcella
    Tito, Claudia
    Capuano, Ernestina
    Masciarelli, Silvia
    Ottone, Tiziana
    Attrotto, Cristina
    Rizzo, Manuela
    Franceschini, Luca
    de Pretis, Stefano
    Voso, Maria Teresa
    Pelizzola, Mattia
    Fazi, Francesco
    Fatica, Alessandro
    CELL DEATH & DISEASE, 2021, 12 (10)